Drug Profile
BAY W 9798
Latest Information Update: 29 May 1995
Price :
$50
*
At a glance
- Originator Bayer
- Class Anti-inflammatories; Dihydropyridines; Peripheral vasodilators; Vascular disorder therapies
- Mechanism of Action Reactive oxygen species inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Peripheral vascular disorders
Most Recent Events
- 29 May 1995 Discontinued-I for Peripheral vascular disorders in Japan (Unknown route)
- 29 May 1995 Discontinued-II for Peripheral vascular disorders in Germany (Unknown route)
- 29 May 1995 Discontinued-II for Peripheral vascular disorders in USA (Unknown route)